These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 37025455)
1. A novel Wu Y; Liu F; Wan R; Jiao B Front Genet; 2023; 14():1153284. PubMed ID: 37025455 [No Abstract] [Full Text] [Related]
2. Clinical and genetic features of luscan-lumish syndrome associated with a novel de novo variant of Zhang Y; Zhang H; Wu W; Wang D; Lv Y; Zhao D; Wang L; Liu Y; Zhang K Front Genet; 2023; 14():1081391. PubMed ID: 36777730 [No Abstract] [Full Text] [Related]
3. Two novel cases expanding the phenotype of SETD2-related overgrowth syndrome. van Rij MC; Hollink IHIM; Terhal PA; Kant SG; Ruivenkamp C; van Haeringen A; Kievit JA; van Belzen MJ Am J Med Genet A; 2018 May; 176(5):1212-1215. PubMed ID: 29681085 [TBL] [Abstract][Full Text] [Related]
4. Clinical Heterogeneity and Different Phenotypes in Patients with Parra A; Rabin R; Pappas J; Pascual P; Cazalla M; Arias P; Gallego-Zazo N; Santana A; Arroyo I; Artigas M; Pachajoa H; Alanay Y; Akgun-Dogan O; Ruaud L; Couque N; Levy J; Porras-Hurtado GL; Santos-Simarro F; Ballesta-Martinez MJ; Guillén-Navarro E; Muñoz-Hernández H; Nevado J; Spanish OverGrowth Registry Initiative ; Tenorio-Castano J; Lapunzina P Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372360 [TBL] [Abstract][Full Text] [Related]
5. A Case of Luscan-Lumish Syndrome: Possible Involvement of Enhanced GH Signaling. Suda K; Fukuoka H; Iguchi G; Kanie K; Fujita Y; Odake Y; Matsumoto R; Bando H; Ito H; Takahashi M; Chihara K; Nagai H; Narumi S; Hasegawa T; Ogawa W; Takahashi Y J Clin Endocrinol Metab; 2021 Mar; 106(3):718-723. PubMed ID: 33248444 [TBL] [Abstract][Full Text] [Related]
9. Case Report: Chinese female patients with a heterozygous pathogenic Cong Y; Jin H; Wu K; Wang H; Wang D Front Genet; 2022; 13():900226. PubMed ID: 36046249 [No Abstract] [Full Text] [Related]
10. Mutation pattern and genotype-phenotype correlations of SETD2 in neurodevelopmental disorders. Chen M; Quan Y; Duan G; Wu H; Bai T; Wang Y; Zhou S; Ou J; Shen Y; Hu Z; Xia K; Guo H Eur J Med Genet; 2021 May; 64(5):104200. PubMed ID: 33766796 [TBL] [Abstract][Full Text] [Related]
11. Genetic analysis and literature review of a Poirier-Bienvenu neurodevelopmental syndrome family line caused by a de novo frameshift variant in CSNK2B. Li D; Zhou B; Tian X; Chen X; Wang Y; Hao S; Zhang C; Hui L Mol Genet Genomic Med; 2024 Jan; 12(1):e2327. PubMed ID: 38037515 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of clinical features and PAK1 gene variant in a child with epilepsy and global developmental delay]. Yuan M; Zhang J; Li Y; Luo H; Zhang J; Gan J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 May; 40(5):552-557. PubMed ID: 37102288 [TBL] [Abstract][Full Text] [Related]
13. Mutations in SETD2 cause a novel overgrowth condition. Luscan A; Laurendeau I; Malan V; Francannet C; Odent S; Giuliano F; Lacombe D; Touraine R; Vidaud M; Pasmant E; Cormier-Daire V J Med Genet; 2014 Aug; 51(8):512-7. PubMed ID: 24852293 [TBL] [Abstract][Full Text] [Related]
14. Cellular and molecular functions of SETD2 in the central nervous system. Mitchell B; Thor S; Piper M J Cell Sci; 2023 Nov; 136(21):. PubMed ID: 37921122 [TBL] [Abstract][Full Text] [Related]
15. Brief Report: SETD2 Mutation in a Child with Autism, Intellectual Disabilities and Epilepsy. Lumish HS; Wynn J; Devinsky O; Chung WK J Autism Dev Disord; 2015 Nov; 45(11):3764-70. PubMed ID: 26084711 [TBL] [Abstract][Full Text] [Related]
16. SETD2 related overgrowth syndrome: Presentation of four new patients and review of the literature. Marzin P; Rondeau S; Aldinger KA; Alessandri JL; Isidor B; Heron D; Keren B; Dobyns WB; Cormier-Daire V Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):509-518. PubMed ID: 31643139 [TBL] [Abstract][Full Text] [Related]
17. De novo variation in EP300 gene cause Rubinstein-Taybi syndrome 2 in a Chinese family with severe early-onset high myopia. Huang X; Rui X; Zhang S; Qi X; Rong W; Sheng X BMC Med Genomics; 2023 Apr; 16(1):84. PubMed ID: 37085840 [TBL] [Abstract][Full Text] [Related]
18. Novel mutation in the Li JR; Huang Z; Lu Y; Ji QY; Jiang MY; Yang F World J Clin Cases; 2020 Dec; 8(24):6465-6472. PubMed ID: 33392332 [TBL] [Abstract][Full Text] [Related]
19. A de novo PAK1 likely pathogenic variant and a de novo terminal 1q microdeletion in a Chinese girl with global developmental delay, severe intellectual disability, and seizures. Zhuang J; Xie M; Yao J; Fu W; Zeng S; Jiang Y; Wang Y; Xie Y; Wang G; Chen C BMC Med Genomics; 2023 Jan; 16(1):3. PubMed ID: 36624491 [TBL] [Abstract][Full Text] [Related]
20. Identification of biallelic mutations in Liu C; Xie Q; Hu Q; Xiang B; Zhao K; Chen X; Zheng F Front Genet; 2024; 15():1405644. PubMed ID: 39228414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]